# Improving HbA1c Levels by Methylcobalamin Vitamin in Diabetic Volunteers

> **NCT06241638** · NA · COMPLETED · sponsor: **Al-Balqa Applied University** · enrollment: 80 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DRUG:** Vitamin B12 0.5 MG/ACTUAT
- **DRUG:** Dapagliflozin 10mg Tab

## Key facts

- **NCT ID:** NCT06241638
- **Lead sponsor:** Al-Balqa Applied University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-01
- **Primary completion:** 2023-06-30
- **Final completion:** 2023-06-30
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2025-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06241638

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06241638, "Improving HbA1c Levels by Methylcobalamin Vitamin in Diabetic Volunteers". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT06241638. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*